These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12424506)

  • 81. Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonist.
    Denker AE; Morelli G; Vessey LK; Li S; Yuan J; Dunbar S; Lewis NM; Taggart W; Wagner JA
    Adv Ther; 2009 Feb; 26(2):230-40. PubMed ID: 19219408
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Digoxin pharmacokinetics and dosage requirements in pediatric patients.
    Bendayan R; McKenzie MW
    Clin Pharm; 1983; 2(3):224-35. PubMed ID: 6349908
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The effect of captopril on pharmacokinetics of digoxin in patients with mild congestive heart failure.
    Miyakawa T; Shionoiri H; Takasaki I; Kobayashi K; Ishii M
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):576-80. PubMed ID: 1711623
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Should pharmacotherapy of digoxin be reviewed in male patients with heart failure in the case of association with carvedilol?
    Souza FC; Neri JS; Marques EB; Barros RB; Scaramello CB
    Int J Cardiol; 2015 Jul; 191():4-6. PubMed ID: 25957928
    [No Abstract]   [Full Text] [Related]  

  • 85. Improved sensitivity of digoxin assay by modification of the EMIT 2000 method.
    Radembino N; Poirier JM; Ragueneau I; Jaillon P
    Ther Drug Monit; 1999 Apr; 21(2):256-8. PubMed ID: 10217349
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40.
    Tayrouz Y; Ding R; Burhenne J; Riedel KD; Weiss J; Hoppe-Tichy T; Haefeli WE; Mikus G
    Clin Pharmacol Ther; 2003 May; 73(5):397-405. PubMed ID: 12732840
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of long-term oral carvedilol on the steady-state pharmacokinetics of oral digoxin in patients with mild to moderate hypertension.
    Wermeling DP; Field CJ; Smith DA; Chandler MH; Clifton GD; Boyle DA
    Pharmacotherapy; 1994; 14(5):600-6. PubMed ID: 7997394
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Population Pharmacokinetic Studies of Digoxin in Adult Patients: A Systematic Review.
    Abdel Jalil M; Abdullah N; Alsous M; Abu-Hammour K
    Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):325-342. PubMed ID: 33616855
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Population Pharmacokinetics of Digoxin in Nonagenarian Patients: Optimization of the Dosing Regimen.
    Salcedo-Mingoarranz AL; Medellín-Garibay SE; Barcia-Hernández E; García-Díaz B
    Clin Pharmacokinet; 2023 Dec; 62(12):1725-1738. PubMed ID: 37816957
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Utility of Physiologically Based Pharmacokinetic Modeling in Point-of-Care Decisions: An Example Using Digoxin Dosing in Continuous Venovenous Hemodiafiltration.
    Srinivasan M; Hirani R; Tsiu M; Kabani K; Chaturvedula A; Palasik B
    Ther Drug Monit; 2020 Feb; 42(1):1-5. PubMed ID: 31593032
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A two-compartment population pharmacokinetic-pharmacodynamic model of digoxin in adults, with implications for dosage.
    Jelliffe RW; Milman M; Schumitzky A; Bayard D; Van Guilder M
    Ther Drug Monit; 2014 Jun; 36(3):387-93. PubMed ID: 24492383
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Therapeutic ranges of serum digoxin concentrations in patients with heart failure.
    Goldberger ZD; Goldberger AL
    Am J Cardiol; 2012 Jun; 109(12):1818-21. PubMed ID: 22502901
    [No Abstract]   [Full Text] [Related]  

  • 94. Digoxin therapy: textbooks, theory and practice.
    Aronson JK; Grahame-Smith DG
    Br J Clin Pharmacol; 1976 Aug; 3(4):639-48. PubMed ID: 22216507
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Population Pharmacokinetics of Digoxin in Duchenne Muscular Dystrophy (DMD) Patients.
    Tateishi M; Ebihara A
    Am J Ther; 1994 Aug; 1(2):144-149. PubMed ID: 11835079
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pharmacokinetics Parameters of Diagoxin among Saudi Patients in Qassim Region, Saudi Arabia.
    Allihimy AS; Almeman AA; Alnassar NA; Almadhi J
    Drug Metab Lett; 2021; 14(2):137-140. PubMed ID: 33970851
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Accidental apixaban intoxication in a 23-month-old child: a case report.
    Launay M; Nasser Y; Maubert I; Chaux AC; Delavenne X
    BMC Pediatr; 2020 Dec; 20(1):546. PubMed ID: 33278889
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population.
    Abdel Jalil MH; Abdullah N; Alsous MM; Saleh M; Abu-Hammour K
    Br J Clin Pharmacol; 2020 Jul; 86(7):1267-1280. PubMed ID: 32153059
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Predicting the serum digoxin concentrations of infants in the neonatal intensive care unit through an artificial neural network.
    Yao SH; Tsai HT; Lin WL; Chen YC; Chou C; Lin HW
    BMC Pediatr; 2019 Dec; 19(1):517. PubMed ID: 31881933
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.